TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 148 filers reported holding TRANSLATE BIO INC in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,093,000 | +78.2% | 693,266 | +6.7% | 0.38% | +61.1% |
| Q1 2021 | $10,717,000 | -9.6% | 649,900 | +1.0% | 0.23% | -6.8% |
| Q4 2020 | $11,860,000 | +35.6% | 643,500 | +0.1% | 0.25% | +13.1% |
| Q3 2020 | $8,746,000 | -26.2% | 642,646 | -2.8% | 0.22% | -31.7% |
| Q2 2020 | $11,850,000 | +44.1% | 661,268 | -19.8% | 0.32% | -4.4% |
| Q1 2020 | $8,225,000 | +6.4% | 825,000 | -13.2% | 0.34% | +39.3% |
| Q4 2019 | $7,733,000 | -23.9% | 950,000 | -7.3% | 0.24% | -39.8% |
| Q3 2019 | $10,158,000 | -20.3% | 1,025,000 | +1.6% | 0.40% | -12.1% |
| Q2 2019 | $12,746,000 | +23.9% | 1,009,179 | 0.0% | 0.46% | +16.4% |
| Q1 2019 | $10,284,000 | +35.9% | 1,009,179 | 0.0% | 0.40% | +10.9% |
| Q4 2018 | $7,569,000 | -25.0% | 1,009,179 | 0.0% | 0.36% | -2.2% |
| Q3 2018 | $10,092,000 | -21.1% | 1,009,179 | -0.2% | 0.36% | -25.8% |
| Q2 2018 | $12,790,000 | – | 1,011,079 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |